Share this article and save a life!
CVS denied 80% of Medicare post-acute care. That is not a glitch.
Let me say that again.
Eighty percent. 🚨
The Medicare Rights Center published data this week showing that the largest Medicare Advantage organizations have disproportionate denial rates for post-acute care. CVS denied 80% of long-term care hospital coverage. Humana denied 72%. UnitedHealth denied 71%. For inpatient rehab facilities, UnitedHealth led with 66%, Humana at 54%, CVS at 51%.
These are not edge cases. These are the dominant patterns of the dominant players.
Here is my take: this is not a claims processing problem. It is a business model problem.
Medicare Advantage was sold to the public as Medicare, but better. More benefits. Lower costs. A private sector upgrade on a clunky government program. What we actually built is a system where private insurers collect a government capitation check, then systematically deny the care that check was meant to fund.
Post-acute care is not elective. Long-term care hospitals and inpatient rehab facilities treat patients who just had strokes, amputations, cardiac events, traumatic brain injuries. These are not people gaming the system. These are people who just survived something catastrophic and need time and clinical support to recover.
Denying 80% of that coverage is not utilization management. It is a revenue strategy dressed up in clinical language.
And the worst part, we have known this for years. The Office of Inspector General has flagged Medicare Advantage denial patterns repeatedly. CMS has tried to tighten oversight. Congress has held hearings. The numbers keep climbing.
Now the counterpoint. The one I hear from insurer defenders constantly.
“Not every denial is inappropriate. Many are overturned on appeal. Prior authorization exists to prevent wasteful spending.”
Fair. All of that is technically true.
But when 7 in 10 post-acute care claims are being denied by the same three companies, you are not catching outliers. You are setting a default that forces patients, families, and providers to fight for care that should be baseline. Most people do not appeal. They do not have the time, the health, the resources, or the knowledge to navigate that process. Denial by attrition is still denial. 💡
At Oatmeal Health, we work in communities that have been structurally left behind by the healthcare system. Lung cancer screening. Preventive care. Early detection. The people we serve are not going to fight a Medicare Advantage denial letter while recovering from a stroke. They are going to go home too soon and end up back in the ER.
The system counts on that passivity.
The boldest thing I can say here is this: if your denial rate for medically necessary post-acute care is 70 to 80 percent, you are not a health plan. You are a bet that sick people will give up.
Question for every Medicare Advantage plan medical director reading this: at what denial rate does your organization consider the system broken, and who in your company is accountable when a patient goes home too early and dies?
👉 Follow for daily healthcare insights. Deeper dives in The Oatmeal Bite on Substack.
Share this article and save a life!
Author:

Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.




